Results 141 to 150 of about 50,656 (201)

The Role of Glucagon-like Peptide-1 Receptor Agonists in Alzheimer's and Parkinson's Disease: A Literature Review of Clinical Trials. [PDF]

Life (Basel)
Pilśniak J, Węgrzynek-Gallina J, Bednarczyk B, Buczek A, Pilśniak A, Chmiela T, Jarosińska A, Siuda J, Holecki M.   +8 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists in total joint arthroplasty: a comprehensive systematic review of what orthopaedic surgeons should know. [PDF]

Arthroplasty
Abdelaziz O, Zayed ZG, Khalafallah MA, Hanafy MA, Hadhoud AM, Elmenawi KA.   +5 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists as a Non-surgical Alternative to Bariatric Surgery for Weight Loss: A Review. [PDF]

Cureus
Steven C, Skylynn T, Bardya H, Megha B, Helen V, Lee D, Entabi F, Pemminati S.   +7 more
europepmc   +1 more source

Research progress on oral glucagon-like peptide-1 receptor agonists in the treatment of diabetes mellitus type 2. [PDF]

Front Mol Biosci
Shao Q, Xiong J, Wu J, Mao J, Hu Q.
europepmc   +1 more source

Cardiorenal protective effects of glucagon-like peptide-1 receptor agonists in chronic kidney disease: a systematic review and meta-analysis. [PDF]

Ren Fail
Wang Y, Feng L, Wang Y, Li B, Liang N, Song X, Qin J, Zhang M, Li Y.   +8 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists and Prior Major Adverse Limb Events in Patients With Diabetes.

JAMA Netw Open
Hsiao FC, Hsu TJ, Hsieh YJ, Tung YC, Chen DY, Lin CP, Chen SW, Chu PH.   +7 more
europepmc   +1 more source

Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists.

JAMA
Klebanoff MJ, Li P, Long JA, Doshi JA.
europepmc   +1 more source

Correction to "Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Obesity Management in Adults With and Without Type 2 Diabetes: A Systematic Review". [PDF]

J Obes
europepmc   +1 more source